Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

233 Views

226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.

Poster Session: Antimicrobial Novel Agents

(2155) Low prevalence of OXA-48-like carbapenemases and susceptibility to imipenem/relebactam among carbapenem-resistant non-Morganellaceae Enterobacterales isolates from Latin America – SMART 2018-2021

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

FS

Fakhar Siddiqui, MD, MBA

Merck & Co., Inc.
Rahway, New Jersey, United States
Thales Polis, MD

Manager
MSD Brazil, Sao Paulo, Brazil
Sao Paulo, Sao Paulo, Brazil
CD

C. Andrew DeRyke, PharmD

Global Director Medical Affairs
Merck & Co., Inc.
Kenilworth, New Jersey, United States
Katherine Young, M.S. (she/her/hers)

Senior Principal Scientist
Merck
Rahway, New Jersey, United States
MM

Mary Motyl, Ph.D.

Distinguished Senior Principal Scientist
Merck
Rahway, New Jersey, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States